Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 7
2008 3
2009 5
2010 5
2011 7
2012 7
2013 5
2014 6
2015 4
2016 2
2017 1
2018 1
2019 2
2023 2
2024 1
2025 1
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
[Sumatriptan-naproxen sodium fix-dose combination for acute migraine treatment, a review].
Tajti J, Csáti A, Szok D. Tajti J, et al. Ideggyogy Sz. 2023 Sep 30;76(9-10):293-296. doi: 10.18071/isz.76.0293. Ideggyogy Sz. 2023. PMID: 37782065 Free article. Review. Hungarian.
Furthermore the combination showed beneficial effect on accompanying symptoms of migraine attack (i.e. nausea, photo- and phonophobia). ...It can be concluded that sumatriptan (85 mg)/naproxen sodium (500 mg) fix-dose combination is effective, safe and well-t …
Furthermore the combination showed beneficial effect on accompanying symptoms of migraine attack (i.e. nausea, photo- and phon …
Sumatriptan-naproxen sodium in migraine: A review.
Wilcha RJ, Afridi SK, Barbanti P, Diener HC, Jürgens TP, Lanteri-Minet M, Lucas C, Mawet J, Moisset X, Russo A, Sacco S, Sinclair AJ, Sumelahti ML, Tassorelli C, Goadsby PJ. Wilcha RJ, et al. Eur J Neurol. 2024 Sep;31 Suppl 2(Suppl 2):e16434. doi: 10.1111/ene.16434. Eur J Neurol. 2024. PMID: 39318200 Free PMC article. Review.
Sumatriptan-naproxen sodium, a single, fixed-dose combination tablet comprising sumatriptan 85 mg and naproxen sodium 500 mg, was developed with the rationale of targeting multiple putative mechanisms involved in the pathogenesis of migraine to optimis …
Sumatriptan-naproxen sodium, a single, fixed-dose combination tablet comprising sumatriptan 85 mg and naproxen sodium 5 …
Sumatriptan/naproxen sodium combination for the treatment of migraine.
Cleves C, Tepper SJ. Cleves C, et al. Expert Rev Neurother. 2008 Sep;8(9):1289-97. doi: 10.1586/14737175.8.9.1289. Expert Rev Neurother. 2008. PMID: 18759540 Review.
Sumatriptan 85 mg with naproxen sodium 500 mg, a combination tablet for the acute treatment of migraine, is approved in the USA. It is likely that triptan/NSAID combination benefits are a class effect, although the majority of data are on sumatriptan and napr …
Sumatriptan 85 mg with naproxen sodium 500 mg, a combination tablet for the acute treatment of migraine, is approved in the US …
Sumatriptan-naproxen fixed combination for acute treatment of migraine: a critical appraisal.
Khoury CK, Couch JR. Khoury CK, et al. Drug Des Devel Ther. 2010 Feb 18;4:9-17. doi: 10.2147/dddt.s8410. Drug Des Devel Ther. 2010. PMID: 20368903 Free PMC article. Review.
They block vasoconstriction and block transmission of signals to the trigeminal nucleus and thus prevent peripheral sensitization. Therefore, combining these two drugs is an attractive modality for the abortive treatment of migraine. Sumatriptan-naproxen …
They block vasoconstriction and block transmission of signals to the trigeminal nucleus and thus prevent peripheral sensitization. Therefore …
Sumatriptan/Naproxen Sodium: A Review in Migraine.
Syed YY. Syed YY. Drugs. 2016 Jan;76(1):111-21. doi: 10.1007/s40265-015-0521-8. Drugs. 2016. PMID: 26628293 Review.
Sumatriptan/naproxen sodium (Treximet ) is a fixed-dose combination of a serotonin 5-HT1B/1D receptor agonist (sumatriptan) and an NSAID (naproxen sodium), approved in the USA for the acute treatment of migraine with or without aura in adolescents and …
Sumatriptan/naproxen sodium (Treximet ) is a fixed-dose combination of a serotonin 5-HT1B/1D receptor agonist (sumatrip …
Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.
Oskoui M, Pringsheim T, Holler-Managan Y, Potrebic S, Billinghurst L, Gloss D, Hershey AD, Licking N, Sowell M, Victorio MC, Gersz EM, Leininger E, Zanitsch H, Yonker M, Mack K. Oskoui M, et al. Neurology. 2019 Sep 10;93(11):487-499. doi: 10.1212/WNL.0000000000008095. Epub 2019 Aug 14. Neurology. 2019. PMID: 31413171
RESULTS: There is evidence to support the efficacy of the use of ibuprofen, acetaminophen (in children and adolescents), and triptans (mainly in adolescents) for the relief of migraine pain, although confidence in the evidence varies between agents. There is high confidenc …
RESULTS: There is evidence to support the efficacy of the use of ibuprofen, acetaminophen (in children and adolescents), and triptans (mainl …
Sumatriptan/naproxen sodium: a review of its use in adult patients with migraine.
Yang LP. Yang LP. Drugs. 2013 Aug;73(12):1339-55. doi: 10.1007/s40265-013-0099-y. Drugs. 2013. PMID: 23912627 Review.
A fixed-dose combination of sumatriptan/naproxen sodium (Treximet( )) has been approved in the US for the acute treatment of migraine in adults. ...Data from longer-term, non-randomized studies support these findings, and the drug combination ap …
A fixed-dose combination of sumatriptan/naproxen sodium (Treximet( )) has been approved in the US for the acute treatme …
The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies.
Marmura MJ, Silberstein SD, Schwedt TJ. Marmura MJ, et al. Headache. 2015 Jan;55(1):3-20. doi: 10.1111/head.12499. Headache. 2015. PMID: 25600718 Review.
The study aims to provide an updated assessment of the evidence for individual pharmacological therapies for acute migraine treatment. Pharmacological therapy is frequently required for acutely treating migraine attacks. ...Effective nonspecific medications include …
The study aims to provide an updated assessment of the evidence for individual pharmacological therapies for acute migraine treatment …
Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials.
Mannix LK, Martin VT, Cady RK, Diamond ML, Lener SE, White JD, Derosier FJ, McDonald SA. Mannix LK, et al. Obstet Gynecol. 2009 Jul;114(1):106-113. doi: 10.1097/AOG.0b013e3181a98e4d. Obstet Gynecol. 2009. PMID: 19546766 Clinical Trial.
OBJECTIVE: To evaluate the efficacy and tolerability of sumatriptan-naproxen during the mild pain phase of a single menstrual migraine attack associated with dysmenorrhea. ...Sumatriptan-naproxen was well-tolerated and resulted in decreased resc …
OBJECTIVE: To evaluate the efficacy and tolerability of sumatriptan-naproxen during the mild pain phase of a single menstrual …
Sumatriptan-naproxen combination for acute migraine.
Charles A, Brennan KC. Charles A, et al. Nat Clin Pract Neurol. 2007 Nov;3(11):604-5. doi: 10.1038/ncpneuro0615. Epub 2007 Sep 11. Nat Clin Pract Neurol. 2007. PMID: 17848929 No abstract available.
56 results